Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Definitive Healthcare Corp. (NASDAQ: DH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Definitive Healthcare is a Delaware corporation focused on healthcare commercial intelligence and healthcare market data and analytics, and its filings provide formal detail on its operations, governance and financial reporting.
Investors can review current reports on Form 8-K, which the company uses to disclose material events such as quarterly financial results, leadership changes and board updates. For example, Form 8-K filings reference earnings press releases for specific quarters and describe items like results of operations, director resignations, committee appointments and executive leadership changes.
In addition to 8-Ks, users can access Definitive Healthcare’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain audited and interim financial statements, management’s discussion and analysis, risk factors, and segment and non-GAAP metric disclosures. These documents expand on metrics highlighted in earnings releases, including Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow.
Stock Titan’s platform enhances these filings with AI-generated summaries that explain key sections, highlight important changes and clarify complex accounting or non-GAAP reconciliations. Real-time updates from EDGAR help ensure that new filings, including any Form 4 insider transaction reports or proxy statements related to executive compensation and governance, appear promptly.
For users researching DH stock, this page offers a structured way to read, compare and understand Definitive Healthcare’s regulatory history, financial reporting practices and corporate actions without manually parsing every line of each SEC document.
Definitive Healthcare Corp. (DH) – Form 3 filing
The filing records the initial beneficial ownership position of newly listed insider Jonathan Paris, who became Chief Legal Officer on 16 June 2025. According to the disclosure, Paris currently reports no direct or indirect ownership of DH securities. An Exhibit 24 Power of Attorney is included, authorising future Section 16 filings on his behalf. No derivatives, options, or other equity instruments are listed. The submission is made on an individual basis and bears a manual signature dated 18 June 2025.
Because no securities are owned and no transactions are reported, the document is largely administrative and carries minimal immediate financial impact for investors.